Oseltamivir 75 mg

DRUG3 trials

Sponsors

University of Manitoba, Janssen Research & Development, LLC, GlaxoSmithKline

Conditions

Influenza AInfluenza A Virus InfectionInfluenza B Virus InfectionVirus Diseases

Phase 2

Study of Acute Uncomplicated Seasonal Influenza A in Adult Subjects

CompletedNCT02342249

Janssen Research & Development, LLCInfluenza A

Start: 2014-12-11End: 2016-05-25Updated: 2025-02-04

Study to Evaluate the Efficacy and Safety of Danirixin Co-administered With Oseltamivir in the Treatment of Adults Hospitalized With Influenza

TerminatedNCT02927431

GlaxoSmithKlineVirus Diseases

Start: 2017-01-19End: 2017-05-24Updated: 2020-11-30

Unknown Phase

Study of the Relative Oral Bioavailability of the Antiflu Medicine Oseltamivir in the Intensive Care Unit

WithdrawnNCT00844155

University of ManitobaInfluenza A Virus Infection, Influenza B Virus Infection

Start: 2009-03-31End: 2009-07-31Updated: 2019-09-17

Related Papers

Efficacy and Safety of Danirixin (GSK1325756) Co-administered With Standard-of-Care Antiviral (Oseltamivir): A Phase 2b, Global, Randomized Study of Adults Hospitalized With Influenza

Open Forum Infectious Diseases2019-04-0129 citations

Phase 2b Study of Pimodivir (JNJ-63623872) as Monotherapy or in Combination With Oseltamivir for Treatment of Acute Uncomplicated Seasonal Influenza A: TOPAZ Trial

The Journal of Infectious Diseases2018-10-25127 citations